Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
ASCO GI 2021
It’s day 4 of SABCS 2023! Today, we’ll be hearing about recent advances in triple negative breast cancer ❗️🔬
http://VJOncology.com will have all the updates from SABCS shortly! 💻
#SABCS23 #BreastCancer #BCsm @SABCSSanAntonio @aacr
📽️@VJOncology are really enjoying catching up on all of the great research going on in #breastcancer at #SABCS23
See our latest coverage here 👉https://www.vjoncology.com/event/sabcs-2023/
#bcsm
🎥Charles Parker, MBBS, of @uclcancer explores the role of digital pathology and AI-derived models in guiding treatment decisions for high-risk prostate cancer:
➡️⬅️
#ESMO23 #PCSM #UroOnc #UroSoMe
Multimodal artificial intelligence models in prostate cancer
Charles Parker, MBBS, UCL Cancer Institute, London, UK, discusses the development of digital pathology-based multimodal ...
ow.ly
It was a pleasure speaking with @VKaklamani of @UTHealthSA and co-director of #SABCS23 yesterday who discussed key take-home messages from the meeting
@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert
It’s day 2 of SABCS 2023! On the agenda today is a state-of-the-art immunotherapy showcase session 💊❗️
Keep up to date with everything SABCS related on http://VJOncology.com 💻
#SABCS23 #BreastCancer #BCsm @SABCSSanAntonio @aacr #ImmunoOnc
ASCO GI 2021
It’s day 4 of SABCS 2023! Today, we’ll be hearing about recent advances in triple negative breast cancer ❗️🔬
http://VJOncology.com will have all the updates from SABCS shortly! 💻
#SABCS23 #BreastCancer #BCsm @SABCSSanAntonio @aacr
📽️@VJOncology are really enjoying catching up on all of the great research going on in #breastcancer at #SABCS23
See our latest coverage here 👉https://www.vjoncology.com/event/sabcs-2023/
#bcsm
🎥Charles Parker, MBBS, of @uclcancer explores the role of digital pathology and AI-derived models in guiding treatment decisions for high-risk prostate cancer:
➡️⬅️
#ESMO23 #PCSM #UroOnc #UroSoMe
Multimodal artificial intelligence models in prostate cancer
Charles Parker, MBBS, UCL Cancer Institute, London, UK, discusses the development of digital pathology-based multimodal ...
ow.ly
It was a pleasure speaking with @VKaklamani of @UTHealthSA and co-director of #SABCS23 yesterday who discussed key take-home messages from the meeting
@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert
It’s day 2 of SABCS 2023! On the agenda today is a state-of-the-art immunotherapy showcase session 💊❗️
Keep up to date with everything SABCS related on http://VJOncology.com 💻
#SABCS23 #BreastCancer #BCsm @SABCSSanAntonio @aacr #ImmunoOnc
